IP Library Granted Patent US 9,422,568
Granted Patent B2
US 9,422,568 · App. 14/059,900 · Granted Aug 23, 2016

Process for preparing L-amino acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,422,568
App. No.
14/059,900
Granted
Aug 23, 2016
Kind
B2
Abstract

A process for preparing L-amino acids employing coryneform bacteria in which the AmtR regulator has been attenuated is provided. Recombinant bacteria, polynucleotides and vectors corresponding to or having the attenuated AmtR regulator are disclosed.

Claims (19)

1. An isolated polynucleotide comprising the promoter region of the amtR gene shown in SEQ ID NO:5 and wherein the amtR gene is attenuated by at least one of

a) replacement of the guanine at position 7 of SEQ ID NO:5 by thymine,

b) replacement of cytosine at position 11 of SEQ ID NO:5 by guanine,

c) replacement of thymine at position 40 of SEQ ID NO:5 by guanine,

d) replacement of thymine at position 45 of SEQ ID NO:5 by guanine,

e) deletion of one or more of the nucleobases of position 40 to 45 of SEQ ID NO:5,

f) deletion of one or more of the nucleobases between position 72 and 78 of SEQ ID NO:5, and

g) replacement of one or more of the nucleobases adenine or guanine between position 72 and 78 of SEQ ID NO:5 by thymine or cytosine.

2. A vector comprising a polynucleotide as claimed in claim 1 .

3. An isolated microorganism cell comprising the vector as claimed in claim 2 .

4. An isolated microorganism cell comprising the polynucleotide as claimed in claim 1 .

5. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by replacement of the guanine at position 7 of SEQ ID NO:5 by thymine.

6. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by replacement of cytosine at position 11 of SEQ ID NO:5 by guanine.

7. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by replacement of thymine at position 40 of SEQ ID NO:5 by guanine.

8. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by replacement of thymine at position 45 of SEQ ID NO:5 by guanine.

9. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by deletion of one or more of the nucleobases of position 40 to 45 of SEQ ID NO:5.

10. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by deletion of all nucleobases of position 40 to 45 of SEQ ID NO:5.

11. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by deletion of one or more of the nucleobases between position 72 and 78 of SEQ ID NO:5.

12. The isolated polynucleotide of claim 1 , wherein the amtR gene is attenuated by replacement of one or more of the nucleobases adenine or guanine between position 72 and 78 of SEQ ID NO:5 by thymine or cytosine.

Assignments (1)
CHANGE OF NAME Recorded Jan 31, 2020
From: EVONIK DEGUSSA GMBH
To: EVONIK OPERATIONS GMBH
Reel/Frame 051765/0166 →